CFGS
REGN icon

Concourse Financial Group Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Concourse Financial Group Securities’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-119
Closed -$80.9K – 1607
2024
Q4 		$80.9K Buy
119
+64
+116% +$53.7K ﹤0.01% 1013
2024
Q3 		$57.8K Buy
55
+9
+20% +$10K ﹤0.01% 1128
2024
Q2 		$48.3K Buy
46
+6
+15% +$5.82K ﹤0.01% 1185
2024
Q1 		$38.5K Buy
40
+12
+43% +$11.4K ﹤0.01% 1298
2023
Q4 		$24.6K Buy
28
+7
+33% +$5.76K ﹤0.01% 1421
2023
Q3 		$17.3K Sell
21
-1
-5% -$786 ﹤0.01% 1488
2023
Q2 		$15.8K Buy
22
+5
+29% +$3.85K ﹤0.01% 1522
2023
Q1 		$14K Hold
17
– – ﹤0.01% 1570
2022
Q4 		$12.3K Buy
17
+5
+42% +$3.69K ﹤0.01% 1587
2022
Q3 		$8K Buy
12
+11
+1,100% +$6.92K ﹤0.01% 1549
2022
Q2 		$1K Sell
1
-5
-83% -$3.25K ﹤0.01% 2134
2022
Q1 		$4K Sell
6
-279
-98% -$177K ﹤0.01% 1912
2021
Q4 		$180K Buy
285
+3
+1% +$1.84K 0.01% 772
2021
Q3 		$171K Buy
282
+36
+15% +$22.3K 0.01% 771
2021
Q2 		$137K Sell
246
-6
-2% -$3.04K 0.01% 854
2021
Q1 		$119K Buy
252
+168
+200% +$81.8K 0.01% 862
2020
Q4 		$41K Sell
84
-124
-60% -$66.9K ﹤0.01% 1213
2020
Q3 		$116K Buy
208
+147
+241% +$89.1K 0.01% 734
2020
Q2 		$38K Buy
61
+6
+11% +$3.41K ﹤0.01% 1078
2020
Q1 		$27K Sell
55
-10
-15% -$4.13K ﹤0.01% 1127
2019
Q4 		$24K Buy
+65
New +$21.9K ﹤0.01% 1205
2019
Q3 		– Sell
-75
Closed -$22.2K – 2073
2019
Q2 		$23K Sell
75
-94
-56% -$31.3K ﹤0.01% 1201
2019
Q1 		$69K Buy
169
+96
+132% +$39.5K 0.01% 772
2018
Q4 		$27K Buy
+73
New +$26.7K ﹤0.01% 1022

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Concourse Financial Group Securities's REGN Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 119 shares — an estimated $80.9K sold.

Concourse Financial Group Securities first reported a position in REGN in Q4 2018 and held it in 24 quarters. The position peaked at $180K in Q4 2021. 1,291 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 119 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $80.9K.
  • Concourse Financial Group Securities first reported a position in Regeneron Pharmaceuticals in Q4 2018 and held it in 24 quarters.
  • Concourse Financial Group Securities's Regeneron Pharmaceuticals position peaked at $180K in Q4 2021.
  • 1,291 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.